Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,112 public trials 3,998 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

NCT05429632

Conditions
Adult Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama Hospital (UAB Hospital) Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
  • University of California Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
View all 111 locations
View Trial Details
Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Dalian, Liaoning, China
View all 25 locations
View Trial Details
Recruiting

PregnAncy-Related Aortic DISsEction in China

NCT07672210

Conditions
Abnormalities, Multiple, Acute Aortic Syndrome, Aneurysm, +37 more
Locations
  • DeltaHealth Hospital Shanghai Shanghai, Shanghai Municipality, China
  • Beijing Anzhen Hospital Beijing, China
  • Guangdong Provincial Hospital Guangzhou, China
  • Wuhan Union Hospital Wuhan, China
View Trial Details
Recruiting

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

NCT02416388

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • CH Amiens Hôpital Sud Amiens, France
  • CHU Angers Angers, France
  • CH Victor Dupouy Argenteuil, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
View all 56 locations
View Trial Details
Recruiting

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

NCT07392242

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions